Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Free Report)’s stock price traded down 1.3% on Friday. The stock traded as low as $3.71 and last traded at $3.89. Approximately 1,212,401 shares traded hands during mid-day trading, an increase of 15% from the average session volume of 1,055,401 shares. The stock had previously closed at $3.94. Key […]

Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report)’s stock price traded up 8.2% on Tuesday. The company traded as high as $19.05 and last traded at $19.1810. Approximately 982,982 shares changed hands during trading, a decline of 68% from the average session volume of 3,087,907 shares. The stock had previously closed at $17.73. Analyst Upgrades […]

Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) shot up 5.5% during mid-day trading on Monday. The company traded as high as $28.49 and last traded at $29.0450. Approximately 122,329 shares changed hands during trading, a decline of 82% from the average session volume of 670,087 shares. The stock had previously closed at $27.53. Wall […]

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) shares rose 5.7% during trading on Monday. The company traded as high as $14.87 and last traded at $15.0670. Approximately 252,044 shares traded hands during trading, a decline of 89% from the average daily volume of 2,307,675 shares. The stock had previously closed at $14.25. Analysts Set […]

Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG – Get Free Report)’s share price shot up 6% on Thursday. The company traded as high as $30.65 and last traded at $30.43. 238,850 shares traded hands during mid-day trading, a decline of 36% from the average session volume of 376,088 shares. The stock had previously closed at $28.70. Analysts […]